325 related articles for article (PubMed ID: 37099161)
21. Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review.
Chen VL; Xu D; Wicha MS; Lok AS; Parikh ND
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2879-2902.e9. PubMed ID: 32289533
[TBL] [Abstract][Full Text] [Related]
22. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.
Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
25. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
Liu M; Zhang Z; Zhang W; Liu SM
WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
[TBL] [Abstract][Full Text] [Related]
26. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
[TBL] [Abstract][Full Text] [Related]
28. TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Akuta N; Kawamura Y; Kobayashi M; Arase Y; Saitoh S; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Suzuki F; Ikeda K; Kumada H
Oncology; 2021; 99(2):114-123. PubMed ID: 32998139
[TBL] [Abstract][Full Text] [Related]
29. Liquid Biopsy in Hepatocellular Carcinoma.
Zhou Z; Xu X; Liu Y; Liu Q; Zhang W; Wang K; Wang J; Yin Y
Methods Mol Biol; 2023; 2695():213-225. PubMed ID: 37450121
[TBL] [Abstract][Full Text] [Related]
30. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
Alunni-Fabbroni M; Rönsch K; Huber T; Cyran CC; Seidensticker M; Mayerle J; Pech M; Basu B; Verslype C; Benckert J; Malfertheiner P; Ricke J
J Transl Med; 2019 Oct; 17(1):328. PubMed ID: 31570105
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
32. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
[TBL] [Abstract][Full Text] [Related]
33. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
Jeepalyam S; Sheel A; Ejaz A; Miller E; Manne A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762533
[TBL] [Abstract][Full Text] [Related]
34. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
Aquino IMC; Pascut D
Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
[TBL] [Abstract][Full Text] [Related]
35. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.
Lehrich BM; Zhang J; Monga SP; Dhanasekaran R
J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635
[TBL] [Abstract][Full Text] [Related]
36. Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy.
Asghar S; Waqar W; Umar M; Manzoor S
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):836-844. PubMed ID: 32312598
[TBL] [Abstract][Full Text] [Related]
37. Circulating Tumor DNA Clinical Applications in Hepatocellular Carcinoma: Current Trends and Future Perspectives.
Bardol T; Pageaux GP; Assenat E; Alix-Panabières C
Clin Chem; 2024 Jan; 70(1):33-48. PubMed ID: 37962158
[TBL] [Abstract][Full Text] [Related]
38. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
39. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
40. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
Shaik MR; Sagar PR; Shaik NA; Randhawa N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]